Obesity and colorectal cancer: Role of adipokines in tumor initiation and progression

World Journal of Gastroenterology

Volumn 20, Issue 18, 2014, Pages 5177-5190

  Riondino, Silvia ^a   Roselli, Mario ^a   Palmirotta, Raffaele ^b   Della Morte, David ^b   Ferroni, Patrizia ^b   Guadagni, Fiorella ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

Adiponectin; Colorectal cancer; Cytokines; Ghrelin; Inflammation; Leptin; Obesity; Resistin

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; GHRELIN; GROWTH FACTOR; INSULIN; INTERLEUKIN 6; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RESISTIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; AUTACOID;

ANGIOGENESIS; ARTICLE; BODY MASS; CANCER GROWTH; CARCINOGENESIS; CELL GROWTH; CELL PROLIFERATION; COLORECTAL CANCER; DISEASE ASSOCIATION; EVIDENCE BASED PRACTICE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; META ANALYSIS (TOPIC); METABOLIC SYNDROME X; MORBIDITY; NONHUMAN; OBESITY; PATHOGENESIS; RISK FACTOR; SYSTEMATIC REVIEW (TOPIC); ANIMAL; CELL TRANSFORMATION; COLORECTAL NEOPLASMS; COMPLICATION; DISEASE COURSE; DISEASE MODEL; INTRAABDOMINAL FAT; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TRANSLATIONAL RESEARCH;

ADIPOKINES; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTRA-ABDOMINAL FAT; OBESITY; RISK FACTORS; SIGNAL TRANSDUCTION; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84900394642     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i18.5177     Document Type: Article

References (137)

1. Moghaddam AA, Woodward M, Huxley R. Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev 2007; 16: 2533-2547 [PMID: 18086756 DOI: 10.1158/1055-9965. EPI-07-0708]
2. Larsson SC, Wolk A. Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr 2007; 86: 556-565 [PMID: 17823417]
3. Lukanova A, Björ O, Kaaks R, Lenner P, Lindahl B, Hallmans G, Stattin P. Body mass index and cancer: results from the Northern Sweden Health and Disease Cohort. Int J Cancer 2006; 118: 458-466 [PMID: 16049963 DOI: 10.1002/ ijc.21354]
4. MacInnis RJ, English DR, Haydon AM, Hopper JL, Gertig DM, Giles GG. Body size and composition and risk of rectal cancer (Australia). Cancer Causes Control 2006; 17: 1291-1297 [PMID: 17111261 DOI: 10.1007/s10552-006-0074-y]
5. Pischon T, Lahmann PH, Boeing H, Friedenreich C, Norat T, Tjønneland A, Halkjaer J, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, Guernec G, Bergmann MM, Linseisen J, Becker N, Trichopoulou A, Trichopoulos D, Sieri S, Palli D, Tumino R, Vineis P, Panico S, Peeters PH, Bueno-de-Mesquita HB, Boshuizen HC, Van Guelpen B, Palmqvist R, Berglund G, Gonzalez CA, Dorronsoro M, Barricarte A, Navarro C, Martinez C, Quirós JR, Roddam A, Allen N, Bingham S, Khaw KT, Ferrari P, Kaaks R, Slimani N, Riboli E. Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2006; 98: 920-931 [PMID: 16818856 DOI: 10.1093/jnci/djj246]
6. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371: 569-578 [PMID: 18280327 DOI: 10.1016/ S0140-6736(08)60269-X]
7. Renehan AG, Soerjomataram I, Tyson M, Egger M, Zwahlen M, Coebergh JW, Buchan I. Incident cancer burden attributable to excess body mass index in 30 European countries. Int J Cancer 2010; 126: 692-702 [PMID: 19645011 DOI: 10.1002/ijc.24803]
8. Aleksandrova K, Pischon T, Buijsse B, May AM, Peeters PH, Bueno-de-Mesquita HB, Jenab M, Fedirko V, Dahm CC, Siersema PD, Freisling H, Ferrari P, Overvad K, Tjønneland A, Trichopoulou A, Lagiou P, Naska A, Pala V, Mattiello A, Ohlsson B, Jirström K, Key TJ, Khaw KT, Riboli E, Boeing H. Adult weight change and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition. Eur J Cancer 2013; 49: 3526-3536 [PMID: 23867126 DOI: 10.1016/j.ejca.2013.06.021]
9. Fernández-Sánchez A, Madrigal-Santillán E, Bautista M, Esquivel-Soto J, Morales-González A, Esquivel-Chirino C, Durante-Montiel I, Sánchez-Rivera G, Valadez-Vega C, Morales-González JA. Inflammation, oxidative stress, and obesity. Int J Mol Sci 2011; 12: 3117-3132 [PMID: 21686173 DOI: 10.3390/ijms12053117]
10. Orgel E, Mittelman SD. The links between insulin resistance, diabetes, and cancer. Curr Diab Rep 2013; 13: 213-222 [PMID: 23271574 DOI: 10.1007/s11892-012-0356-6]
11. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and metaregression analysis. Lancet 2004; 363: 1346-1353 [PMID: 15110491 DOI: 10.1016/S0140-6736(04)16044-3]
12. Bardou M, Barkun AN, Martel M. Republished: obesity and colorectal cancer. Postgrad Med J 2013; 89: 519-533 [PMID: 23955330 DOI: 10.1136/postgradmedj-2013-304701rep]
13. Wozniak SE, Gee LL, Wachtel MS, Frezza EE. Adipose tissue: the new endocrine organ? A review article. Dig Dis Sci 2009; 54: 1847-1856 [PMID: 19052866 DOI: 10.1007/ s10620-008-0585-3]
14. Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 2007; 56: 1010-1013 [PMID: 17287468 DOI: 10.2337/db06-1656]
15. Cypess AM, Lehman S, Williams G, Tal I, Rodman D, Goldfine AB, Kuo FC, Palmer EL, Tseng YH, Doria A, Kolodny GM, Kahn CR. Identification and importance of brown adipose tissue in adult humans. N Engl J Med 2009; 360: 1509-1517 [PMID: 19357406 DOI: 10.1056/NEJMoa0810780]
16. Bays HE, Toth PP, Kris-Etherton PM, Abate N, Aronne LJ, Brown WV, Gonzalez-Campoy JM, Jones SR, Kumar R, La Forge R, Samuel VT. Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association. J Clin Lipidol 2013; 7: 304-383 [PMID: 23890517 DOI: 10.1016/ j.jacl.2013.04.001]
17. Smas CM, Sul HS. Control of adipocyte differentiation. Biochem J 1995; 309 (Pt 3): 697-710 [PMID: 7639681]
18. Bays HE, González-Campoy JM, Henry RR, Bergman DA, Kitabchi AE, Schorr AB, Rodbard HW. Is adiposopathy (sick fat) an endocrine disease? Int J Clin Pract 2008; 62: 1474-1483 [PMID: 18681905 DOI: 10.1111/j.1742-1241.2008.01848.x]
19. Bays H. Adiposopathy: role of adipocyte factors in a new paradigm. Expert Rev Cardiovasc Ther 2005; 3: 187-189 [PMID: 15853591 DOI: 10.1586/14779072.3.2.187]
20. Harvey AE, Lashinger LM, Hursting SD. The growing challenge of obesity and cancer: an inflammatory issue. Ann N Y Acad Sci 2011; 1229: 45-52 [PMID: 21793838 DOI: 10.1111/ j.1749-6632.2011.06096.x]
21. Kursawe R, Eszlinger M, Narayan D, Liu T, Bazuine M, Cali AM, D'Adamo E, Shaw M, Pierpont B, Shulman GI, Cushman SW, Sherman A, Caprio S. Cellularity and adipogenic profile of the abdominal subcutaneous adipose tissue from obese adolescents: association with insulin resistance and hepatic steatosis. Diabetes 2010; 59: 2288-2296 [PMID: 20805387 DOI: 10.2337/db10-0113]
22. O'Rourke RW. Inflammation in obesity-related diseases. Surgery 2009; 145: 255-259 [PMID: 19231576 DOI: 10.1016/ j.surg.2008.08.038]
23. Rizzo A, Pallone F, Monteleone G, Fantini MC. Intestinal inflammation and colorectal cancer: a double-edged sword? World J Gastroenterol 2011; 17: 3092-3100 [PMID: 21912451 DOI: 10.3748/wjg.v17.i26.3092]
24. Cousin B, Munoz O, Andre M, Fontanilles AM, Dani C, Cousin JL, Laharrague P, Casteilla L, Pénicaud L. A role for preadipocytes as macrophage-like cells. FASEB J 1999; 13: 305-312 [PMID: 9973318]
25. Dalmas E, Clément K, Guerre-Millo M. Defining macrophage phenotype and function in adipose tissue. Trends Immunol 2011; 32: 307-314 [PMID: 21616718 DOI: 10.1016/ j.it.2011.04.008]
26. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1808 [PMID: 14679176 DOI: 10.1172/JCI19246]
27. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007; 117: 175-184 [PMID: 17200717 DOI: 10.1172/JCI29881]
28. Hao NB, Lü MH, Fan YH, Cao YL, Zhang ZR, Yang SM. Macrophages in tumor microenvironments and the progression of tumors. Clin Dev Immunol 2012; 2012: 948098 [PMID: 22778768 DOI: 10.1155/2012/948098]
29. Suganami T, Nishida J, Ogawa Y. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler Thromb Vasc Biol 2005; 25: 2062-2068 [PMID: 16123319 DOI: 10.1161/01.ATV.0000183883.72263.13]
30. Huang XF, Chen JZ. Obesity, the PI3K/Akt signal pathway and colon cancer. Obes Rev 2009; 10: 610-616 [PMID: 19527447 DOI: 10.1111/j.1467-789X.2009.00607.x]
31. Yehuda-Shnaidman E, Schwartz B. Mechanisms linking obesity, inflammation and altered metabolism to colon carcinogenesis. Obes Rev 2012; 13: 1083-1095 [PMID: 22937964 DOI: 10.1111/j.1467-789X.2012.01024.x]
32. Dirat B, Bochet L, Escourrou G, Valet P, Muller C. Unraveling the obesity and breast cancer links: a role for cancerassociated adipocytes? Endocr Dev 2010; 19: 45-52 [PMID: 20551667 DOI: 10.1159/000316896]
33. Ramos-Nino ME. The role of chronic inflammation in obesity-associated cancers. ISRN Oncol 2013; 2013: 697521 [PMID: 23819063 DOI: 10.1155/2013/697521]
34. Braun S, Bitton-Worms K, LeRoith D. The link between the metabolic syndrome and cancer. Int J Biol Sci 2011; 7: 1003-1015 [PMID: 21912508 DOI: 10.7150/ijbs.7.1003]
35. Zick Y. Role of Ser/Thr kinases in the uncoupling of insulin signaling. Int J Obes Relat Metab Disord 2003; 27 Suppl 3: S56-S60 [PMID: 14704747 DOI: 10.1038/sj.ijo.0802503]
36. Shoelson SE, Lee J, Yuan M. Inflammation and the IKK beta/ I kappa B/NF-kappa B axis in obesity-and diet-induced in-sulin resistance. Int J Obes Relat Metab Disord 2003; 27 Suppl 3: S49-S52 [PMID: 14704745 DOI: 10.1038/sj.ijo.0802501]
37. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-820 [PMID: 11742414 DOI: 10.1038/414813a]
38. Kant P, Hull MA. Excess body weight and obesity--the link with gastrointestinal and hepatobiliary cancer. Nat Rev Gastroenterol Hepatol 2011; 8: 224-238 [PMID: 21386810 DOI: 10.1038/nrgastro.2011.23]
39. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995; 270: 26746-26749 [PMID: 7592907 DOI: 10.1074/jbc.270.45.26746]
40. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adiposespecific gene dysregulated in obesity. J Biol Chem 1996; 271: 10697-10703 [PMID: 8631877 DOI: 10.1074/jbc.271.18.10697]
41. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006; 116: 1784-1792 [PMID: 16823476 DOI: 10.1172/ JCI29126]
42. Nakashima R, Kamei N, Yamane K, Nakanishi S, Nakashima A, Kohno N. Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans. J Clin Endocrinol Metab 2006; 91: 3873-3877 [PMID: 16882743 DOI: 10.1210/jc.2006-1158]
43. Hanley AJ, Bowden D, Wagenknecht LE, Balasubramanyam A, Langfeld C, Saad MF, Rotter JI, Guo X, Chen YD, Bryer-Ash M, Norris JM, Haffner SM. Associations of adiponectin with body fat distribution and insulin sensitivity in nondiabetic Hispanics and African-Americans. J Clin Endocrinol Metab 2007; 92: 2665-2671 [PMID: 17426091 DOI: 10.1210/jc.2006-2614]
44. Scheid MP, Sweeney G. The role of adiponectin signaling in metabolic syndrome and cancer. Rev Endocr Metab Disord 2013 Sep 10; Epub ahead of print [PMID: 24019064 DOI: 10.1007/s11154-013-9265-5]
45. Xu Y, He B, Pan Y, Gu L, Nie Z, Chen L, Li R, Gao T, Wang S. The roles of ADIPOQ genetic variations in cancer risk: evidence from published studies. Mol Biol Rep 2013; 40: 1135-1144 [PMID: 23065236]
46. Drew JE, Farquharson AJ, Padidar S, Duthie GG, Mercer JG, Arthur JR, Morrice PC, Barrera LN. Insulin, leptin, and adiponectin receptors in colon: regulation relative to differing body adiposity independent of diet and in response to dimethylhydrazine. Am J Physiol Gastrointest Liver Physiol 2007; 293: G682-G691 [PMID: 17656443 DOI: 10.1152/ajpgi. 00231.2007]
47. Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Okamoto Y, Ishigami M, Kuriyama H, Kishida K, Nishizawa H, Hotta K, Muraguchi M, Ohmoto Y, Yamashita S, Funahashi T, Matsuzawa Y. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001; 103: 1057-1063 [PMID: 11222466 DOI: 10.1161/01.CIR.100.25.2473]
48. Gialamas SP, Petridou ET, Tseleni-Balafouta S, Spyridopoulos TN, Matsoukis IL, Kondi-Pafiti A, Zografos G, Mantzoros CS. Serum adiponectin levels and tissue expression of adiponectin receptors are associated with risk, stage, and grade of colorectal cancer. Metabolism 2011; 60: 1530-1538 [PMID: 21632074 DOI: 10.1016/j.metabol.2011.03.020]
49. Koerner A, Kratzsch J, Kiess W. Adipocytokines: leptin--the classical, resistin--the controversical, adiponectin--the promising, and more to come. Best Pract Res Clin Endocrinol Metab 2005; 19: 525-546 [PMID: 16311215 DOI: 10.1016/ j.beem.2005.07.008]
50. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432 [PMID: 7984236 DOI: 10.1038/372425a0]
51. Somasundar P, Riggs D, Jackson B, Vona-Davis L, McFadden DW. Leptin stimulates esophageal adenocarcinoma growth by nonapoptotic mechanisms. Am J Surg 2003; 186: 575-578 [PMID: 14599628 DOI: 10.1016/j.amjsurg.2003.07.017]
52. Pai R, Lin C, Tran T, Tarnawski A. Leptin activates STAT and ERK2 pathways and induces gastric cancer cell proliferation. Biochem Biophys Res Commun 2005; 331: 984-992 [PMID: 15882975]
53. Aparicio T, Kotelevets L, Tsocas A, Laigneau JP, Sobhani I, Chastre E, Lehy T. Leptin stimulates the proliferation of human colon cancer cells in vitro but does not promote the growth of colon cancer xenografts in nude mice or intestinal tumorigenesis in Apc(Min/+) mice. Gut 2005; 54: 1136-1145 [PMID: 15857934 DOI: 10.1136/gut.2004.060533]
54. Hardwick JC, Van Den Brink GR, Offerhaus GJ, Van Deventer SJ, Peppelenbosch MP. Leptin is a growth factor for colonic epithelial cells. Gastroenterology 2001; 121: 79-90 [PMID: 11438496 DOI: 10.1053/gast.2001.25490]
55. Rouet-Benzineb P, Aparicio T, Guilmeau S, Pouzet C, Descatoire V, Buyse M, Bado A. Leptin counteracts sodium butyrate-induced apoptosis in human colon cancer HT-29 cells via NF-kappaB signaling. J Biol Chem 2004; 279: 16495-16502 [PMID: 14752104 DOI: 10.1074/jbc.M312999200]
56. Hoda MR, Keely SJ, Bertelsen LS, Junger WG, Dharmasena D, Barrett KE. Leptin acts as a mitogenic and antiapoptotic factor for colonic cancer cells. Br J Surg 2007; 94: 346-354 [PMID: 17212381 DOI: 10.1002/bjs.5530]
57. Amemori S, Ootani A, Aoki S, Fujise T, Shimoda R, Kakimoto T, Shiraishi R, Sakata Y, Tsunada S, Iwakiri R, Fujimoto K. Adipocytes and preadipocytes promote the proliferation of colon cancer cells in vitro. Am J Physiol Gastrointest Liver Physiol 2007; 292: G923-G929 [PMID: 17170030 DOI: 10.1152/ajpgi.00145.2006]
58. Attoub S, Noe V, Pirola L, Bruyneel E, Chastre E, Mareel M, Wymann MP, Gespach C. Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, rho-, and rac-dependent signaling pathways. FASEB J 2000; 14: 2329-2338 [PMID: 11053255 DOI: 10.1096/ fj.00-0162]
59. Koda M, Sulkowska M, Kanczuga-Koda L, Surmacz E, Sulkowski S. Overexpression of the obesity hormone leptin in human colorectal cancer. J Clin Pathol 2007; 60: 902-906 [PMID: 17660334 DOI: 10.1136/jcp.2006.041004]
60. Paik SS, Jang SM, Jang KS, Lee KH, Choi D, Jang SJ. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma. Ann Surg Oncol 2009; 16: 297-303 [PMID: 19050975 DOI: 10.1245/s10434-008-0221-7]
61. Ribatti D, Nico B, Belloni AS, Vacca A, Roncali L, Nussdorfer GG. Angiogenic activity of leptin in the chick embryo chorioallantoic membrane is in part mediated by endogenous fibroblast growth factor-2. Int J Mol Med 2001; 8: 265-268 [PMID: 11494053]
62. Vona-Davis L, Rose DP. Angiogenesis, adipokines and breast cancer. Cytokine Growth Factor Rev 2009; 20: 193-201 [PMID: 19520599 DOI: 10.1016/j.cytogfr.2009.05.007]
63. Gonzalez RR, Cherfils S, Escobar M, Yoo JH, Carino C, Styer AK, Sullivan BT, Sakamoto H, Olawaiye A, Serikawa T, Lynch MP, Rueda BR. Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (VEGF) and its receptor type two (VEGF-R2). J Biol Chem 2006; 281: 26320-26328 [PMID: 16825198 DOI: 10.1074/jbc.M601991200]
64. Sikalidis AK, Varamini B. Roles of hormones and signaling molecules in describing the relationship between obesity and colon cancer. Pathol Oncol Res 2011; 17: 785-790 [PMID: 21221874 DOI: 10.1007/s12253-010-9352-9]
65. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA. The hormone resistin links obesity to diabetes. Nature 2001; 409: 307-312 [PMID: 11201732 DOI: 10.1038/35053000]
66. Ikeda Y, Tsuchiya H, Hama S, Kajimoto K, Kogure K. Resistin affects lipid metabolism during adipocyte maturation of 3T3-L1 cells. FEBS J 2013; 280: 5884-5895 [PMID: 24034627 DOI: 10.1111/febs.12514]
67. Mojiminiyi OA, Abdella NA. Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus. Scand J Clin Lab Invest 2007; 67: 215-225 [PMID: 17366001 DOI: 10.1080/00365510601032532]
68. Filková M, Haluzík M, Gay S, Senolt L. The role of resistin as a regulator of inflammation: Implications for various human pathologies. Clin Immunol 2009; 133: 157-170 [PMID: 19740705 DOI: 10.1016/j.clim.2009.07.013]
69. Karapanagiotou EM, Tsochatzis EA, Dilana KD, Tourkantonis I, Gratsias I, Syrigos KN. The significance of leptin, adiponectin, and resistin serum levels in non-small cell lung cancer (NSCLC). Lung Cancer 2008; 61: 391-397 [PMID: 18342391 DOI: 10.1016/j.lungcan.2008.01.018]
70. Tiaka EK, Manolakis AC, Kapsoritakis AN, Potamianos SP. The implication of adiponectin and resistin in gastrointestinal diseases. Cytokine Growth Factor Rev 2011; 22: 109-119 [PMID: 21531165 DOI: 10.1016/j.cytogfr.2011.04.002]
71. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656-660 [PMID: 10604470 DOI: 10.1038/45230]
72. Baragli A, Lanfranco F, Allasia S, Granata R, Ghigo E. Neuroendocrine and metabolic activities of ghrelin gene products. Peptides 2011; 32: 2323-2332 [PMID: 22056513 DOI: 10.1016/ j.peptides.2011.10.024]
73. Jeffery PL, Herington AC, Chopin LK. The potential autocrine/ paracrine roles of ghrelin and its receptor in hormone-dependent cancer. Cytokine Growth Factor Rev 2003; 14: 113-122 [PMID: 12651223 DOI: 10.1677/joe.0.172R007]
74. Thompson NM, Gill DA, Davies R, Loveridge N, Houston PA, Robinson IC, Wells T. Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor. Endocrinology 2004; 145: 234-242 [PMID: 14551228 DOI: 10.1210/en.2003-0899]
75. Cassoni P, Ghé C, Marrocco T, Tarabra E, Allia E, Catapano F, Deghenghi R, Ghigo E, Papotti M, Muccioli G. Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines. Eur J Endocrinol 2004; 150: 173-184 [PMID: 14763915 DOI: 10.1530/eje.0.1500173]
76. Joint statement of the role of the registered nurse in the care of the patient with cardiovascular diseases in coronary care or intensive care units; approved by the Maryland Nurses Association. Md Nurs News 1967; 36: 43-44 [PMID: 5183037 DOI: 10.1016/j.yfrne.2004.03.002]
77. Barzon L, Pacenti M, Masi G, Stefani AL, Fincati K, Palù G. Loss of growth hormone secretagogue receptor 1a and overexpression of type 1b receptor transcripts in human adrenocortical tumors. Oncology 2005; 68: 414-421 [PMID: 16020971 DOI: 10.1159/000086983]
78. Bustin SA, Jenkins PJ. The growth hormone-insulin-like growth factor-I axis and colorectal cancer. Trends Mol Med 2001; 7: 447-454 [PMID: 11597519 DOI: 10.1016/S1471-4914(01)02104-9]
79. Moon HS, Liu X, Nagel JM, Chamberland JP, Diakopoulos KN, Brinkoetter MT, Hatziapostolou M, Wu Y, Robson SC, Iliopoulos D, Mantzoros CS. Salutary effects of adiponectin on colon cancer: in vivo and in vitro studies in mice. Gut 2013; 62: 561-570 [PMID: 22735569 DOI: 10.1136/gutjnl-2012-302092]
80. Bråkenhielm E, Veitonmäki N, Cao R, Kihara S, Matsuzawa Y, Zhivotovsky B, Funahashi T, Cao Y. Adiponectininduced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci USA 2004; 101: 2476-2481 [PMID: 14983034 DOI: 10.1073/pnas.0308671100]
81. Adya R, Tan BK, Chen J, Randeva HS. Protective actions of globular and full-length adiponectin on human endothelial cells: novel insights into adiponectin-induced angiogenesis. J Vasc Res 2012; 49: 534-543 [PMID: 22964477 DOI: 10.1159/000338279]
82. Kim AY, Lee YS, Kim KH, Lee JH, Lee HK, Jang SH, Kim SE, Lee GY, Lee JW, Jung SA, Chung HY, Jeong S, Kim JB. Adiponectin represses colon cancer cell proliferation via AdipoR1-and-R2-mediated AMPK activation. Mol Endocrinol 2010; 24: 1441-1452 [PMID: 20444885 DOI: 10.1210/ me.2009-0498]
83. Jaffe T, Schwartz B. Leptin promotes motility and invasiveness in human colon cancer cells by activating multiple signal-transduction pathways. Int J Cancer 2008; 123: 2543-2556 [PMID: 18767036 DOI: 10.1002/ijc.23821]
84. Wang D, Chen J, Chen H, Duan Z, Xu Q, Wei M, Wang L, Zhong M. Leptin regulates proliferation and apoptosis of colorectal carcinoma through PI3K/Akt/mTOR signalling pathway. J Biosci 2012; 37: 91-101 [PMID: 22357207 DOI: 10.1007/s12038-011-9172-4]
85. Uchiyama T, Takahashi H, Endo H, Sugiyama M, Sakai E, Hosono K, Nagashima Y, Inayama Y, Wada K, Hippo Y, Nakajima A. Role of the long form leptin receptor and of the STAT3 signaling pathway in colorectal cancer progression. Int J Oncol 2011; 39: 935-940 [PMID: 21720710 DOI: 10.3892/ ijo.2011.1105]
86. Sarraf P, Frederich RC, Turner EM, Ma G, Jaskowiak NT, Rivet DJ, Flier JS, Lowell BB, Fraker DL, Alexander HR. Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J Exp Med 1997; 185: 171-175 [PMID: 8996253 DOI: 10.1084/jem.185.1.171]
87. Fenton JI, Hord NG. Stage matters: choosing relevant model systems to address hypotheses in diet and cancer chemoprevention research. Carcinogenesis 2006; 27: 893-902 [PMID: 16474168 DOI: 10.1093/carcin/bgi355]
88. Fenton JI, Hursting SD, Perkins SN, Hord NG. Leptin induces an Apc genotype-associated colon epithelial cell chemokine production pattern associated with macrophage chemotaxis and activation. Carcinogenesis 2007; 28: 455-464 [PMID: 16891627 DOI: 10.1093/carcin/bgl137]
89. Zheng LD, Tong QS, Weng MX, He J, Lv Q, Pu JR, Jiang GS, Cai JB, Liu Y, Hou XH. Enhanced expression of resistin-like molecule beta in human colon cancer and its clinical significance. Dig Dis Sci 2009; 54: 274-281 [PMID: 18594973 DOI: 10.1007/s10620-008-0355-2]
90. Lawnicka H, Mełeń-Mucha G, Motylewska E, Mucha S, Ste{ogonek}pień H. Modulation of ghrelin axis influences the growth of colonic and prostatic cancer cells in vitro. Pharmacol Rep 2012; 64: 951-959 [PMID: 23087147]
91. Bonfili L, Cuccioloni M, Cecarini V, Mozzicafreddo M, Palermo FA, Cocci P, Angeletti M, Eleuteri AM. Ghrelin induces apoptosis in colon adenocarcinoma cells via proteasome inhibition and autophagy induction. Apoptosis 2013; 18: 1188-1200 [PMID: 23632965 DOI: 10.1007/s10495-013-0856-0]
92. Sikalidis AK, Fitch MD, Fleming SE. Diet induced obesity increases the risk of colonic tumorigenesis in mice. Pathol Oncol Res 2013; 19: 657-666 [PMID: 23536280 DOI: 10.1007/ s12253-013-9626-0]
93. Mutoh M, Teraoka N, Takasu S, Takahashi M, Onuma K, Yamamoto M, Kubota N, Iseki T, Kadowaki T, Sugimura T, Wakabayashi K. Loss of adiponectin promotes intestinal carcinogenesis in Min and wild-type mice. Gastroenterology 2011; 140: 2000-208, 2000-208, [PMID: 21334339 DOI: 10.1053/j.gastro.2011.02.019]
94. Otani K, Kitayama J, Yasuda K, Nio Y, Iwabu M, Okudaira S, Aoki J, Yamauchi T, Kadowaki T, Nagawa H. Adiponectin suppresses tumorigenesis in Apc(Min)(/+) mice. Cancer Lett 2010; 288: 177-182 [PMID: 19646806 DOI: 10.1016/ j.canlet.2009.06.037]
95. Saxena A, Chumanevich A, Fletcher E, Larsen B, Lattwein K, Kaur K, Fayad R. Adiponectin deficiency: role in chronic inflammation induced colon cancer. Biochim Biophys Acta 2012; 1822: 527-536 [PMID: 22198319 DOI: 10.1016/j.bbadis.2011.12.006]
96. Boddicker RL, Whitley E, Birt DF, Spurlock ME. Early lesion formation in colorectal carcinogenesis is associated with adiponectin status whereas neoplastic lesions are associated with diet and sex in C57BL/6J mice. Nutr Cancer 2011; 63: 1297-1306 [PMID: 21958077 DOI: 10.1080/01635581. 2011.606954]
97. Fujisawa T, Endo H, Tomimoto A, Sugiyama M, Takahashi H, Saito S, Inamori M, Nakajima N, Watanabe M, Kubota N, Yamauchi T, Kadowaki T, Wada K, Nakagama H, Nakajima A. Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition. Gut 2008; 57: 1531-1538 [PMID: 18676419 DOI: 10.1136/gut.2008.159293]
98. Sikalidis AK, Fitch MD, Fleming SE. Risk of colonic cancer is not higher in the obese Lep(ob) mouse model compared to lean littermates. Pathol Oncol Res 2013; 19: 867-874 [PMID: 23813464 DOI: 10.1007/s12253-013-9656-7]
99. Hirose Y, Hata K, Kuno T, Yoshida K, Sakata K, Yamada Y, Tanaka T, Reddy BS, Mori H. Enhancement of development of azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db mice. Carcinogenesis 2004; 25: 821-825 [PMID: 14729596 DOI: 10.1093/carcin/bgh059]
100. Endo H, Hosono K, Uchiyama T, Sakai E, Sugiyama M, Takahashi H, Nakajima N, Wada K, Takeda K, Nakagama H, Nakajima A. Leptin acts as a growth factor for colorectal tumours at stages subsequent to tumour initiation in murine colon carcinogenesis. Gut 2011; 60: 1363-1371 [PMID: 21406387 DOI: 10.1136/gut.2010.235754]
101. Ikeda Y, Hama S, Kajimoto K, Okuno T, Tsuchiya H, Kogure K. Quantitative comparison of adipocytokine gene expression during adipocyte maturation in non-obese and obese rats. Biol Pharm Bull 2011; 34: 865-870 [PMID: 21628885 DOI: 10.1248/bpb.34.865]
102. An W, Bai Y, Deng SX, Gao J, Ben QW, Cai QC, Zhang HG, Li ZS. Adiponectin levels in patients with colorectal cancer and adenoma: a meta-analysis. Eur J Cancer Prev 2012; 21: 126-133 [PMID: 21960184 DOI: 10.1097/CEJ.0b013e32834c9b55]
103. Wei EK, Giovannucci E, Fuchs CS, Willett WC, Mantzoros CS. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst 2005; 97: 1688-1694 [PMID: 16288122 DOI: 10.1093/jnci/dji376]
104. Otake S, Takeda H, Suzuki Y, Fukui T, Watanabe S, Ishihama K, Saito T, Togashi H, Nakamura T, Matsuzawa Y, Kawata S. Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance. Clin Cancer Res 2005; 11: 3642-3646 [PMID: 15897559 DOI: 10.1158/1078-0432. CCR-04-1868]
105. Ferroni P, Palmirotta R, Spila A, Martini F, Raparelli V, Fossile E, Mariotti S, Del Monte G, Buonomo O, Roselli M, Guadagni F. Prognostic significance of adiponectin levels in non-metastatic colorectal cancer. Anticancer Res 2007; 27: 483-489 [PMID: 17348431]
106. Gonullu G, Kahraman H, Bedir A, Bektas A, Yücel I. Association between adiponectin, resistin, insulin resistance, and colorectal tumors. Int J Colorectal Dis 2010; 25: 205-212 [PMID: 19888587 DOI: 10.1007/s00384-009-0828]
107. Lukanova A, Söderberg S, Kaaks R, Jellum E, Stattin P. Serum adiponectin is not associated with risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2006; 15: 401-402 [PMID: 16492937 DOI: 10.1158/1055-9965.EPI-05-0836]
108. Fukumoto J, Otake T, Tajima O, Tabata S, Abe H, Mizoue T, Ohnaka K, Kono S. Adiponectin and colorectal adenomas: Self Defense Forces Health Study. Cancer Sci 2008; 99: 781-786 [PMID: 18377427 DOI: 10.1111/j.1349-7006.2008.00745.x]
109. Stocks T, Lukanova A, Johansson M, Rinaldi S, Palmqvist R, Hallmans G, Kaaks R, Stattin P. Components of the metabolic syndrome and colorectal cancer risk; a prospective study. Int J Obes (Lond) 2008; 32: 304-314 [PMID: 17878894 DOI: 10.1038/sj.ijo.0803713]
110. Wolf I, Sadetzki S, Kanety H, Kundel Y, Pariente C, Epstein N, Oberman B, Catane R, Kaufman B, Shimon I. Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients. Cancer 2006; 106: 966-973 [PMID: 16411208 DOI: 10.1002/cncr.21690]
111. Stattin P, Palmqvist R, Söderberg S, Biessy C, Ardnor B, Hallmans G, Kaaks R, Olsson T. Plasma leptin and colorectal cancer risk: a prospective study in Northern Sweden. Oncol Rep 2003; 10: 2015-2021 [PMID: 14534736]
112. Stattin P, Lukanova A, Biessy C, Söderberg S, Palmqvist R, Kaaks R, Olsson T, Jellum E. Obesity and colon cancer: does leptin provide a link? Int J Cancer 2004; 109: 149-152 [PMID: 14735482 DOI: 10.1002/ijc.11668]
113. Tamakoshi K, Toyoshima H, Wakai K, Kojima M, Suzuki K, Watanabe Y, Hayakawa N, Yatsuya H, Kondo T, Tokudome S, Hashimoto S, Suzuki S, Kawado M, Ozasa K, Ito Y, Tamakoshi A. Leptin is associated with an increased female colorectal cancer risk: a nested case-control study in Japan. Oncology 2005; 68: 454-461 [PMID: 16020976 DOI: 10.1159/000086988]
114. Tutino V, Notarnicola M, Guerra V, Lorusso D, Caruso MG. Increased soluble leptin receptor levels are associated with advanced tumor stage in colorectal cancer patients. Anticancer Res 2011; 31: 3381-3383 [PMID: 21965750]
115. Healy LA, Howard JM, Ryan AM, Beddy P, Mehigan B, Stephens R, Reynolds JV. Metabolic syndrome and leptin are associated with adverse pathological features in male colorectal cancer patients. Colorectal Dis 2012; 14: 157-165 [PMID: 21689278 DOI: 10.1111/j.1463-1318.2011.02562.x]
116. Wallace AM, Sattar N, Mcmillan DC. The co-ordinated cytokine/hormone response to acute injury incorporates leptin. Cytokine 2000; 12: 1042-1045 [PMID: 10880250]
117. Bolukbas FF, Kilic H, Bolukbas C, Gumus M, Horoz M, Turhal NS, Kavakli B. Serum leptin concentration and advanced gastrointestinal cancers: a case controlled study. BMC Cancer 2004; 4: 29 [PMID: 15217519 DOI: 10.1186/1471-2407-4-29]
118. Erarslan E, Turkay C, Koktener A, Koca C, Uz B, Bavbek N. Association of visceral fat accumulation and adiponectin levels with colorectal neoplasia. Dig Dis Sci 2009; 54: 862-868 [PMID: 18716871 DOI: 10.1007/s10620-008-0440-6]
119. Guadagni F, Roselli M, Martini F, Spila A, Riondino S, D' Alessandro R, Del Monte G, Formica V, Laudisi A, Portarena I, Palmirotta R, Ferroni P. Prognostic significance of serum adipokine levels in colorectal cancer patients. Anticancer Res 2009; 29: 3321-3327 [PMID: 19661351]
120. Byeon JS, Jeong JY, Kim MJ, Lee SM, Nam WH, Myung SJ, Kim JG, Yang SK, Kim JH, Suh DJ. Adiponectin and adiponectin receptor in relation to colorectal cancer progression. Int J Cancer 2010; 127: 2758-2767 [PMID: 21351255 DOI: 10.1002/ijc.25301]
121. Aleksandrova K, Boeing H, Jenab M, Bueno-de-Mesquita HB, Jansen E, van Duijnhoven FJ, Fedirko V, Rinaldi S, Romieu I, Riboli E, Romaguera D, Westphal S, Overvad K, Tjønneland A, Boutron-Ruault MC, Clavel-Chapelon F, Kaaks R, Lukanova A, Trichopoulou A, Lagiou P, Trichopoulos D, Agnoli C, Mattiello A, Saieva C, Vineis P, Tumino R, Peeters PH, Argüelles M, Bonet C, Sánchez MJ, Dorronsoro M, Huerta JM, Barricarte A, Palmqvist R, Hallmans G, Khaw KT, Wareham N, Allen NE, Crowe FL, Pischon T. Total and high-molecular weight adiponectin and risk of colorectal cancer: the European Prospective Investigation into Cancer and Nutrition Study. Carcinogenesis 2012; 33: 1211-1218 [PMID: 22431719 DOI: 10.1093/carcin/bgs133]
122. Song M, Zhang X, Wu K, Ogino S, Fuchs CS, Giovannucci EL, Chan AT. Plasma adiponectin and soluble leptin receptor and risk of colorectal cancer: a prospective study. Can-cer Prev Res (Phila) 2013; 6: 875-885 [PMID: 23872505 DOI: 10.1158/1940-6207.CAPR-13-0169]
123. Sǎlǎgeanu A, Tucureanu C, Lerescu L, Caraş I, Pitica R, Gangurà G, Costea R, Neagu S. Serum levels of adipokines resistin and leptin in patients with colon cancer. J Med Life 2010; 3: 416-420 [PMID: 21254741]
124. Steppan CM, Lazar MA. The current biology of resistin. J Intern Med 2004; 255: 439-447 [PMID: 15049878 DOI: 10.1111/ j.1365-2796.2004.01306.x]
125. Kumor A, Daniel P, Pietruczuk M, Małecka-Panas E. Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients. Int J Colorectal Dis 2009; 24: 275-281 [PMID: 18979105 DOI: 10.1007/s00384-008-0605-y]
126. Nakajima TE, Yamada Y, Hamano T, Furuta K, Matsuda T, Fujita S, Kato K, Hamaguchi T, Shimada Y. Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer. Cancer Sci 2010; 101: 1286-1291 [PMID: 20331631 DOI: 10.1111/j.1349-7006.2010.01518.x]
127. Danese E, Montagnana M, Minicozzi AM, Bonafini S, Ruzzenente O, Gelati M, De Manzoni G, Lippi G, Guidi GC. The role of resistin in colorectal cancer. Clin Chim Acta 2012; 413: 760-764 [PMID: 22296675 DOI: 10.1016/j.cca.2012.01.019]
128. Waseem T, Javaid-Ur-Rehman F, Azam M, Qureshi MA. Role of ghrelin axis in colorectal cancer: a novel association. Peptides 2008; 29: 1369-1376 [PMID: 18471933 DOI: 10.1016/ j.peptides.2008.03.020]
129. D'Onghia V, Leoncini R, Carli R, Santoro A, Giglioni S, Sorbellini F, Marzocca G, Bernini A, Campagna S, Marinello E, Vannoni D. Circulating gastrin and ghrelin levels in patients with colorectal cancer: correlation with tumour stage, Helicobacter pylori infection and BMI. Biomed Pharmacother 2007; 61: 137-141 [PMID: 17258885 DOI: 10.1016/j.biopha.2006.08.007]
130. Kemik O, Sumer A, Kemik AS, Hasirci I, Purisa S, Dulger AC, Demiriz B, Tuzun S. The relationship among acutephase response proteins, cytokines and hormones in cachectic patients with colon cancer. World J Surg Oncol 2010; 8: 85 [PMID: 20920199 DOI: 10.1186/1477-7819-8-85]
131. Win AK, Macinnis RJ, Hopper JL, Jenkins MA. Risk prediction models for colorectal cancer: a review. Cancer Epidemiol Biomarkers Prev 2012; 21: 398-410 [PMID: 22169185 DOI: 10.1158/1055-9965.EPI-11-0771]
132. Johnson IT, Lund EK. Review article: nutrition, obesity and colorectal cancer. Aliment Pharmacol Ther 2007; 26: 161-181 [PMID: 17593063 DOI: 10.1111/j.1365-2036.2007.03371.x]
133. Drew JE. Molecular mechanisms linking adipokines to obesity-related colon cancer: focus on leptin. Proc Nutr Soc 2012; 71: 175-180 [PMID: 22014041 DOI: 10.1017/S0029665111003259]
134. Irwin ML. Physical activity interventions for cancer survivors. Br J Sports Med 2009; 43: 32-38 [PMID: 18948351 DOI: 10.1136/bjsm.2008.053843]
135. Jeon JY, Meyerhardt JA. Energy in and energy out: what matters for survivors of colorectal cancer? J Clin Oncol 2012; 30: 7-10 [PMID: 22124098 DOI: 10.1200/JCO.2011.39.6374]
136. Vazzana N, Riondino S, Toto V, Guadagni F, Roselli M, Davi G, Ferroni P. Obesity-driven inflammation and colorectal cancer. Curr Med Chem 2012; 19: 5837-5853 [PMID: 23033947 DOI: 10.2174/092986712804143349]
137. Jeon J, Sato K, Niedzwiecki D, Ye X, Saltz LB, Mayer RJ, Mowat RB, Whittom R, Hantel A, Benson A, Wigler DS, Atienza D, Messino M, Kindler H, Venook A, Fuchs CS, Meyerhardt JA. Impact of physical activity after cancer diagnosis on survival in patients with recurrent colon cancer: Findings from CALGB 89803/Alliance. Clin Colorectal Cancer 2013; 12: 233-238 [PMID: 24035029]